Skip to main content
EJNMMI Research
Fig. 1 | EJNMMI Research

Fig. 1

From: Repeatability of tumor blood flow quantification with 82Rubidium PET/CT in prostate cancer — a test-retest study

Fig. 1

Images of two patients in the study. a Patient 2, a high-risk patient with a Gleason 5+4 high-flow tumor and metastatic disease. To the left, 68Ga-prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) with automatically drawn volumes of interest (VOIs) from standard uptake value (SUV) 6 fixed threshold in blue. The first 82Rb PET/CT scan in the middle and the second scan to the right. b Patient 9, a low-risk patient in active surveillance with a low-flow tumor. To the left, t2-weighted magnetic resonance imaging with hand-drawn VOIs in light blue. The first 82Rb PET/CT scan in the middle and the second scan to the right

Back to article page